Publication | Open Access

Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma

HepatologyMacro Cd5l+MedicineLiver PhysiologyHepatobiliary TumorImmunologyBiliary CancerPathologyCd8+t Cells ExhaustionLiver CancerCancer TreatmentGemcitabine-oxaliplatin-lenvatinib-anti-pd1 TherapyOncologyTumor Microenvironment